Veterinary Medicine Information website

TOXIPRA PLUS SUSPENSION INYECTABLE PARA BOVINO, CAPRINO, OVINO, PORCINO Y CONEJOS

Authorised
  • Clostridium tetani, toxoid
  • Clostridium chauvoei, cells and toxin, Inactivated
  • Clostridium septicum, toxoid
  • Clostridium novyi, type B, alpha toxoid
  • Clostridium perfringens, type B, C and D, epsilon toxoid
  • Clostridium perfringens, type B, C and D, beta toxoid

Product identification

Medicine name:
TOXIPRA PLUS SUSPENSION INYECTABLE PARA BOVINO, CAPRINO, OVINO, PORCINO Y CONEJOS
Active substance:
  • Clostridium tetani, toxoid
  • Clostridium chauvoei, cells and toxin, Inactivated
  • Clostridium septicum, toxoid
  • Clostridium novyi, type B, alpha toxoid
  • Clostridium perfringens, type B, C and D, epsilon toxoid
  • Clostridium perfringens, type B, C and D, beta toxoid
Target species:
  • Cattle (calf)
  • Sheep (lamb)
  • Pig (piglet)
  • Rabbit (female for reproduction)
  • Goat (kid)
  • Sheep
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium tetani, toxoid
    2.50
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium chauvoei, cells and toxin, Inactivated
    100.00
    percentage protection
    /
    1.00
    millilitre(s)
  • Clostridium septicum, toxoid
    2.50
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium novyi, type B, alpha toxoid
    3.50
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, type B, C and D, epsilon toxoid
    5.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, type B, C and D, beta toxoid
    10.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle (calf)
      • Meat and offal
        0
        day
    • Sheep (lamb)
      • Meat and offal
        0
        day
    • Pig (piglet)
      • Meat and offal
        0
        day
    • Rabbit (female for reproduction)
      • Meat and offal
        0
        day
    • Goat (kid)
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Cattle (calf)
      • Meat and offal
        0
        day
    • Sheep (lamb)
      • Meat and offal
        0
        day
    • Pig (piglet)
      • Meat and offal
        0
        day
    • Rabbit (female for reproduction)
      • Meat and offal
        0
        day
    • Goat (kid)
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB01
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 2820 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 28/05/2025

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 28/05/2025

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 15/04/2025